LBA40 Neoadjuvant nivolumab and nivolumab plus ipilimumab induce (near-) complete responses in patients with head and neck squamous cell carcinoma: The IMCISION trial

L. Zuur, Joris L. Vos, Joris B.W. Elbers, Oscar Krijgsman, Xiaohang Qiao, Anne M. van der Leun, Laura A. Smit, Michiel W. M. van den Brekel, Brandon Tan, Bas Jasperse, Wouter V. Vogel, Stefan M. Willems, Abrahim Al‐Mamgani, Daniel S. Peeper, Ton N. Schumacher, Christian U. Blank, Jan Paul de Boer, John B.A.G. Haanen